Do NOACs and ABC pathway adherence improve hierarchical composite outcomes compared to warfarin and nonadherence in patients with atrial fibrillation?
In patients with atrial fibrillation, the use of NOACs and adherence to the ABC pathway significantly improve hierarchical composite outcomes compared to warfarin and nonadherence.
This Win Ratio analysis demonstrates the significant benefits of NOACs over warfarin and ABC pathway adherence over nonadherence in reducing the composite outcome in patients with AF.
Treewaree et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: